Dr. Emmy Kinya Kinoti
Oncology Pharmacist – Meru Teaching and Referral Hospital (MeTRH)
Quick Facts
- Experience: ~5 years in oncology pharmacy practice
- Current Studies: Master in Oncology Pharmacy, Kabarak University
- Previous Role: Team Lead, Oncology Unit Pharmacists – MeTRH
- Key Achievement: Abstract presenter, Anchor Conference 2022
Where You Live Should Not Determine Whether You Live or Die
Dr. Kinoti's career is driven by a firm belief in equitable access to quality oncology care — particularly in public facilities serving underserved communities across Kenya.
Professional Overview
Dr. Emmy Kinya Kinoti is a trained pharmacist with approximately five years of dedicated experience in oncology pharmacy practice. She holds a Bachelor of Pharmacy degree and, until her residency, was an active practitioner in the Oncology Unit at Meru Teaching and Referral Hospital (MeTRH). She is currently pursuing a Master in Oncology Pharmacy at Kabarak University, deepening her academic and clinical expertise in cancer care.
Dr. Kinoti has received both formal and informal oncology training from a range of distinguished institutions including the International Cancer Institute, the National Cancer Control Program (Ministry of Health, Kenya), BVGH, and SASOPH in partnership with ESOP. Her practice is grounded in a passion for offering comfort and hope to oncology patients, and she is a committed advocate for restoring public confidence in the quality of cancer care delivered in public health facilities.
Areas of Clinical Excellence
Oncology Unit Leadership
Served as team lead for pharmacists working in the Oncology Unit at MeTRH, coordinating pharmaceutical care delivery and supporting team development
MDT Coordination
Played a central role in the coordination of multidisciplinary team (MDT) meetings at MeTRH, ensuring pharmacist input was embedded in cancer treatment planning
Pharmacy Education & Training
Active contributor to the training and mentorship of pharmacy students and interns at MeTRH, building the next generation of oncology pharmacists
Cancer Screening & Early Detection
Developed and institutionalised a lung cancer screening tool at MeTRH, strengthening early detection capacity at a regional referral facility
Abstract Presenter – Anchor Conference 2022
Selected to present an abstract at the Anchor Conference in 2022, contributing original oncology pharmacy insights to a national professional audience and demonstrating her growing contribution to evidence-based practice.
Education & Training
Master in Oncology Pharmacy – Kabarak University
CurrentPursuing advanced postgraduate studies in oncology pharmacy, building on her clinical experience with rigorous academic training in cancer pharmacotherapy and practice.
Bachelor of Pharmacy
UndergraduateFoundational pharmacy training providing the clinical and pharmaceutical sciences knowledge underpinning her specialisation in oncology.
Oncology Training – International Cancer Institute
Continuing EducationFormal training in oncology principles and practice, supplementing her hands-on clinical experience with structured institutional learning.
National Cancer Control Program – Ministry of Health, Kenya
Continuing EducationEngagement with Kenya's national cancer control framework, equipping her with policy-level understanding of cancer care priorities and implementation strategies.
SASOPH / ESOP & BVGH Training
Continuing EducationReceived oncology pharmacy training through the SASOPH partnership with ESOP and through BVGH, reinforcing her international perspective on cancer care practice.
Contributions to Practice Development
Beyond direct patient care, Dr. Kinoti has made meaningful contributions to strengthening oncology pharmacy infrastructure and systems at MeTRH and at the national level:
- SOP Development: Developed standard operating procedures for the MeTRH Oncology Unit, establishing consistent, evidence-based protocols to guide safe and effective pharmaceutical practice
- Lung Cancer Screening Tool: Designed and institutionalised a lung cancer screening tool at MeTRH, contributing to earlier diagnosis and improved patient outcomes in a resource-limited setting
- Pharmacy Student & Intern Training: Played a key role in the practical training of pharmacy students and interns, embedding oncology competencies in the next generation of practitioners
- MDT Integration: Championed the pharmacist's role within MDT structures at MeTRH, ensuring pharmaceutical expertise informs every stage of the cancer care pathway
- Conference Dissemination: Presented research at the Anchor Conference 2022, sharing practice insights and contributing to the national oncology pharmacy knowledge base
National Task Force Involvement
Dr. Kinoti is actively engaged in national working groups that shape the future of oncology pharmacy and cancer care delivery in Kenya:
Oncology Pharmacy Supply Chain TWG
Contributing to national efforts to strengthen the procurement, storage, and distribution of oncology medicines to ensure consistent availability at facilities across Kenya
National Childhood Cancer Task Workforce
Supporting Kenya's national agenda for improving paediatric cancer outcomes through coordinated, multidisciplinary workforce development and care delivery
Professional Memberships & Engagement
Dr. Kinoti is an active member of key professional organisations that connect her to the broader oncology pharmacy community nationally and internationally:
Her involvement with OPSOK as the Member Engagement lead reflects her commitment to building a vibrant, connected community of oncology pharmacy professionals in Kenya — ensuring members are supported, informed, and empowered to advance their practice.
Vision for Oncology Pharmacy
Dr. Kinoti is motivated by a deeply held conviction that geography should not determine a patient's access to life-saving cancer care. Her vision for oncology pharmacy is shaped by several guiding principles:
Equity in Cancer Care: Ensuring that patients in public facilities and rural or peri-urban settings receive the same standard of oncology pharmaceutical care as those in private or urban hospitals.
Comfort and Hope: Believing that the role of the oncology pharmacist extends beyond dispensing — it includes being a consistent, trusted presence that offers patients and families reassurance throughout their treatment journey.
Strengthening Public Facilities: Advocating for investment in pharmacy infrastructure, workforce capacity, and supply chains at public hospitals so that quality oncology care is not the preserve of private healthcare.
Education and Mentorship: Cultivating a culture of learning within oncology pharmacy, investing in the growth of students, interns, and junior colleagues to build a resilient workforce for the future.
Restoring Faith in Public Cancer Care
"I enjoy offering comfort and hope to oncology patients. I firmly believe that where you live should not determine whether you live or die."
